ApprovalTrail

Approval · Notice of Compliance 9659 · 2008

TRIDURAL: Notice of Compliance 9659

Issued July 2, 2008

A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.

Notice number
9659
Date
July 2, 2008
Product type
Prescription Pharmaceutical
Submission
Supplement to a New Drug Submission (SNDS), supplement
Submission class
Other
Reason
Revision to the indication from pain of moderate severity to moderate to moderately severe pain
Therapeutic class
Opioid analgesic

Products in this notice

BrandDINStatus today
TRIDURALNot yet assigned—

Medicinal ingredients